Fas expression in primary breast cancer is related to neoplastic infiltration of perilymphatic fat

Bębenek, M.; Duś, D.; Koźlak, J.
June 2008
Advances in Medical Sciences (De Gruyter Open);2008, Vol. 53 Issue 1, p49
Academic Journal
Purpose: Various studies have revealed that both Fas and its ligand play an important role in cancer biology. The aim of our study was to determine if there is a relationship between the expression of Fas or Fas-ligand in breast cancer and the presence of malignant cells in perilymphatic fat. Material/Methods: Tumor samples from 147 consecutive breast cancer patients, aged 35-81 (median, 59), were subjected to analysis. The expressions of Fas and Fas-ligand were determined immunohistochemically. Results: The expression of Fas, but not Fas-ligand, was significantly less frequent in breast cancer patients in whom malignant cells infiltrated through the perilymphatic fat (p=0.042). The infiltration of paranodal fatty tissue occurred more often in cases of ductal carcinomas (p=0.008), larger primary tumors (pT≥2, p=0.030) and regional lymph node involvement (pN≥1, p=O.021). Univariate analysis revealed that perilymphatic fat infiltration shortened overall survivals in breast cancer patients (p=0.05), similarly to postmenopausal status (p=0.034), age >60 years (p=0.05) and regional lymph node involvement (p=0.05). None of the aforementioned factors, however, was revealed as an independent predictor of survival in multivariate analysis. Conclusions: The study showed that lack of Fas in primary breast cancer is associated with perilymphatic fat infiltration. Consequently, both the absence of Fas in the primary tumor and the occurrence of neoplatic cells in paranodal fatty tissue should be considered in the prognosis, complementing existing conventional factors.


Related Articles

  • Prognostic Factors Affecting Postmastectomy Locoregional Recurrence in Patients with Early Breast Cancer: Are Intrinsic Subtypes Effective? Mersin, Hakan; Gülben, Kaptan; Berberoğlu, Uğur; Yazι, Mete; Acun, Gökçe; Kιnaş, Volkan; Erdoğan, Şükrü // World Journal of Surgery;Oct2011, Vol. 35 Issue 10, p2196 

    Background: Many studies have investigated the association between the molecular subtypes of breast cancer and survival. The aim of this study was to identify the effects of intrinsic subtypes of breast cancer and the other clinicopathological factors on postmastectomy locoregional recurrence...

  • Association between molecular subtypes and lymph node status in invasive breast cancer. Chengshuai Si; Yiting Jin; Hongying Wang; Qiang Zou // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 10, p6800 

    Background: The predictors for the involvement of lymph node (LN) have been widely studied. But the implication of the molecular type has not been well studied. Using the database of our institution, we investigated this relation. Methods: Patients with T1 and T2 primary breast cancer without...

  • The hottest sentinel lymph node is not always the positive node. Camp, E. R.; Cendan, J. C.; Feezor, R.; Lind, D. S.; Wilkinson, E.; Copeland, E. M. // American Surgeon;Jun2004, Vol. 70 Issue 6, p475 

    The technique of identifying the sentinel lymph node (SLN) varies from each individual institution. Generally, the highest isotope count in a lymph node is considered the SLN, whereas other radioactive nodes might also be removed. The purpose of our study was to determine if the hottest node was...

  • Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer. Britto, Anna V.; Schenka, André A.; Moraes-Schenka, Natália G.; Alvarenga, Marcelo; Shinzato, Júlia Y.; Vassallo, José; Ward, Laura S. // BMC Cancer;2009, Vol. 9, Special section p1 

    Background: Sentinel lymph node (SLN) biopsy is a widely used diagnostic procedure in the management of early breast cancer. When SLN is free of metastasis, complete axillary dissection may be skipped for staging in clinically N0 patients, allowing a more conservative procedure. Histological...

  • Lymph Node Ratio: A New Feature for Defining Risk Category of Node-Positive Breast Cancer Patients. Yang, Cuicui; Liu, Fangfang; Li, Shuai; Li, Weidong; Zhai, Lili; Ren, Meijing; Li, Yaqing; Lang, Ronggang; Fan, Yu; Zhang, Xinmin; Fu, Li // International Journal of Surgical Pathology;Dec2012, Vol. 20 Issue 6, p546 

    St. Gallen 2005 expert consensus guideline modified its criteria for the risk category of breast cancer (BC) patients by integrating a combination of lymph nodes with metastasis (positive lymph nodes [PLNs]) and HER-2/neu status of tumor. Recently, some studies have shown that lymph node ratio...

  • Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients. Hee Ji Han; Ju Ree Kim; Hee Rim Nam; Ki Chang Keum; Chang Ok Suh; Yong Bae Kim // Radiation Oncology Journal;Sep2014, Vol. 32 Issue 3, p132 

    Purpose: To evaluate non-sentinel lymph node (LN) status after sentinel lymph node biopsy (SNB) in patients with breast cancer and to identify the predictive factors for disease failure. Materials and Methods: From January 2006 to December 2007, axillary lymph node (ALN) dissection after SNB was...

  • A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome. Zekri, J. M.; Ibrahim, E.; Ben Sadiq, B.; Al-Gahmi, A. M.; Zeeneldin, A. A.; Elkhodary, T. R.; Gaballa, H. E.; Fawzy, E. E.; Elsayed, M. E.; Bahadur, Y.; Awadalla, S.; Alzahran, M. S. // Ecancermedicalscience;2010, Vol. 4, p1 

    Introduction: Genetic profile studies of breast cancer identified a number of biologically different subtypes. These genetic subtypes are often surrogated by oestrogen receptors (ERs), progesterone receptors (PR) and HER2 status as measured by immunohistochemistry (IHC). Triple negative (TN)...

  • Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients. Ataseven, B.; Kümmel, S.; Weikel, W.; Heitz, F.; Holtschmidt, J.; Lorenz-Salehi, F.; Kümmel, A.; Traut, A.; Blohmer, J.; Harter, P.; Bois, A. // Archives of Gynecology & Obstetrics;May2015, Vol. 291 Issue 5, p1153 

    Purpose: Although the impact of lymph node ratio (LNR: ratio of metastatic to resected LNs) in breast cancer (BC) has been investigated, its prognostic value in molecular subtypes remains unclear. Our aim was to evaluate the impact of LNR compared to pN-stage in BC subtypes. Patients/methods: We...

  • Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. Zhengbin Shen; Shuang Zhou; Yanna Wang; Ri-lun Li; Cuiping Zhong; Chunmin Liang; Yihong Sun // Journal of Cancer Research & Clinical Oncology;Oct2010, Vol. 136 Issue 10, p1585 

    The aim of the present study was to investigate the prognostic value of tumor-infiltrated lymphocytes (TILs), especially the prognostic value of Foxp3+ regulatory T cells (Tregs), CD8+ CTLs and Tregs/CD8+ ratios in gastric cancer patients after R0 resection. From 133 patients, CD4+, CD8+ and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics